Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pragmatic Clinical Trial to Elucidate Optimal Target Population of Immunotherapy From Real-world Lung Cancer Patients

NCT04909164 is registered in ClinicalTrials.gov with Myung-Ju Ahn as lead sponsor.

NCT NCT04909164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04909164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pragmatic Clinical Trial to Elucidate Optimal Target Population of Immunotherapy From Real-world Lung Cancer Patients
Lead sponsor
Myung-Ju Ahn
Phase
Observational
Overall status
Completed
Start date
June 15, 2021
Completion date
July 30, 2026
Enrollment
1,519 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)